id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0399-0006,FDA,FDA-2008-D-0399,International Conference on Harmonisation: Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions  Annex 5: Disintegration Test General Chapter,Notice,NAD-Notice of Availability of Data,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2009-12-23T19:06:42Z,E9-30441,0,0,0900006480a70631
FDA-2008-D-0399-0007,FDA,FDA-2008-D-0399,"Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions, Annex 5 Disintegration Test General Chapter - Guidance for Industry",Other,GDL-Guidance (Supporting and Related Materials),2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2024-11-12T04:49:00Z,,1,0,0900006480a70857
FDA-2008-D-0399-0001,FDA,FDA-2008-D-0399,International Conference on Harmonisation: Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Disintegration Test General Chapter; Availability,Notice,NAD-Notice of Availability of Data,2008-08-05T04:00:00Z,2008,8,2008-08-05T04:00:00Z,2008-10-07T03:59:59Z,2024-11-12T04:16:40Z,E8-17864,1,0,09000064806aecee
FDA-2008-D-0399-0002,FDA,FDA-2008-D-0399,Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions - Annex 5: Disintegration Test General Chapter,Other,GDL-Guidance (Supporting and Related Materials),2008-08-05T04:00:00Z,2008,8,2008-08-05T04:00:00Z,,2024-11-12T04:23:15Z,,1,0,09000064806af023